Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Disease Progression and RET[original query] |
|---|
| Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 2003 Sep 134 (3): 425-31. Machens Andreas, Holzhausen Hans-Jürgen, Thanh Phuong Nguyen, Dralle Henni |
| CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma. European journal of endocrinology / European Federation of Endocrine Societies 2011 Mar 164 (3): 397-404. Pasquali Daniela, Circelli Luisa, Faggiano Antongiulio, Pancione Massimo, Renzullo Andrea, Elisei Rossella, Romei Cristina, Accardo Giacomo, Coppola Viviana Raffaella, De Palma Maurizio, Ferolla Piero, Grimaldi Franco, Colao Annamaria, Colantuoni Vittor |
| Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. The Journal of clinical endocrinology and metabolism 2013 Sep 98 (9): E1562-6. Landa Iñigo, Ganly Ian, Chan Timothy A, Mitsutake Norisato, Matsuse Michiko, Ibrahimpasic Tihana, Ghossein Ronald A, Fagin James |
| Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. The Journal of clinical endocrinology and metabolism 2013 May 98 (5): E829-36. Sabra M M, Dominguez J M, Grewal R K, Larson S M, Ghossein R A, Tuttle R M, Fagin J |
| Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid : official journal of the American Thyroid Association 2014 Aug 24 (8): 1256-66. Zou Minjing, Baitei Essa Y, Alzahrani Ali S, BinHumaid Faisal S, Alkhafaji Dania, Al-Rijjal Roua A, Meyer Brian F, Shi Yuf |
| Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. Journal of the American Academy of Dermatology 2016 Sep 75 (3): 595-602. Lawrence Nicholas F, Hammond Marc R, Frederick Dennie T, Su Yuhua, Dias-Santagata Dora, Deng April, Selim M Angelica, Mahalingam Meera, Flaherty Keith T, Hoang Mai |
| Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients. BMC cancer 2016 Nov 16 (1): 864. Ko Ryo, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Wakuda Kazushige, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Isaka Mitsuhiro, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyuki, Takahashi Kazuhisa, Takahashi Toshia |
| Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid : official journal of the American Thyroid Association 2016 Sep . Grubbs Elizabeth G, Williams Michelle D, Scheet Paul, Vattathil Selina, Perrier Nancy, Lee Jeffrey E, Gagel Robert F, Hai Tao, Feng Lei, Cabanillas Maria, Cote Gilbert |
| Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma. Molecular medicine reports 2015 Dec . Nascimento Fabrício P, Cardoso Mirian G, Lindsey Susan C, Kunii Ilda S, Valente Flávia O F, Kizys Marina M L, Delcelo Rosana, Camacho Cléber P, Maciel Rui M B, Dias-Da-Silva Magnus |
| Familial MTC with RET exon 8 Gly533Cys mutation: origin and prevalence of second malignancy. Endocrine connections 2017 9 6 (8): 676-684. Saltiki Katerina, Anagnostou Elli, Simeakis George, Kouki Sofia, Angelopoulou Anastasia, Sarika Leda, Papathoma Alexandra, Alevizaki Mar |
| Germline BRCA1 Mutation Detected in a Multiple Endocrine Neoplasia Type 2 Case With RET Codon 634 Mutation. Frontiers in genetics 2019 7 10 544. Sarkadi Balázs, Baghy Kornélia, Sápi Zoltán, Nyir? Gábor, Likó István, Patócs Atti |
| Outcomes to first-line pembrolizumab in patients with PD-L1-high (?50%) non-small cell lung cancer and a poor performance status. Journal for immunotherapy of cancer 2020 8 8 (2): . Alessi Joao V, Ricciuti Biagio, Jiménez-Aguilar Elizabeth, Hong Fangxin, Wei Zihan, Nishino Mizuki, Plodkowski Andrew J, Sawan Peter, Luo Jia, Rizvi Hira, Carter Brett W, Heymach John V, Altan Mehmet, Hellmann Matthew, Awad Ma |
| Discrepancies of RET gene and risk of differentiated thyroid carcinoma. Cancer biomarkers : section A of Disease markers 2021 Jul . Rashid Faiza A, Khan Mosin S, Tabassum Sobia, Aiman Aiffa, Jadoon Maharij |
| Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency. Clinical lung cancer 2021 1 22 (4): e519-e527. Bustamante Alvarez Jean G, Janse Sarah, Owen Dwight H, Kiourtsis Stephanie, Bertino Erin M, He Kai, Carbone David P, Otterson Gregory |
| Hereditary medullary thyroid carcinoma syndromes: experience from western India. Familial cancer 2021 1 20 (3): 241-251. Diwaker Chakra, Sarathi Vijaya, Jaiswal Sanjeet Kumar, Shah Ravikumar, Deshmukh Anuja, Thomas Anand Ebin, Prakash Gagan, Malhotra Gaurav, Patil Virendra, Lila Anurag, Shah Nalini, Bandgar Tush |
| Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series study. Respiratory investigation 2022 9 60 (6): 852-856. Seki Yoshitaka, Yoshida Tatsuya, Kohno Takashi, Masuda Ken, Okuma Yusuke, Goto Yasushi, Horinouchi Hidehito, Yamamoto Noboru, Kuwano Kazuyoshi, Ohe Yuichi |
| Selpercatinib monotherapy in a Chinese patient with RET fusion/EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report. Anti-cancer drugs 2023 6 . Lin Wu, Ying Cheng, Dingzhi Huang, Yuping Sun, Chengzhi Zhou, Jianying Zhou, Ye Guo, Jingxin Shao, Wanli Zhang, Shun |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance. The Journal of clinical endocrinology and metabolism 2024 8 . Teresa Ramone, Arianna Ghirri, Alessandro Prete, Antonio Matrone, Raffaele Ciampi, Paolo Piaggi, Maria Scutari, Teresa Rago, Liborio Torregrossa, Cristina Romei, Rossella Elisei, Eleonora Molina |
| Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-institution Cohort of 2,390 patients. World neurosurgery 2024 6 . Danny John, Mohammed Alshalalfa, Timoteo Almeida, Anna Murray, Joao Marques, Gregory Azzam, Eric A Mellon, Carolina G Benjamin, Ricardo J Komotar, Michael Ivan, Brandon Mahal, Benjamin J Ri |
- Page last reviewed:Feb 1, 2024
- Content source: